Cargando…

A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium

The contrast-induced acute kidney injury (CI-AKI) has been becoming the third common cause of hospital-acquired acute kidney injury. An ideal animal model is essential for understanding the pathophysiology of CI-AKI. Previous CI-AKI studies were mostly performed on rats with high-osmolar contrast me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jiajia, Shen, Jianxiao, Wang, Wanpeng, Jiang, Na, Jin, Haijiao, Che, Xiajing, Ni, Zhaohui, Fang, Yan, Mou, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367657/
https://www.ncbi.nlm.nih.gov/pubmed/35938700
http://dx.doi.org/10.1080/0886022X.2022.2108449
_version_ 1784765874669879296
author Wu, Jiajia
Shen, Jianxiao
Wang, Wanpeng
Jiang, Na
Jin, Haijiao
Che, Xiajing
Ni, Zhaohui
Fang, Yan
Mou, Shan
author_facet Wu, Jiajia
Shen, Jianxiao
Wang, Wanpeng
Jiang, Na
Jin, Haijiao
Che, Xiajing
Ni, Zhaohui
Fang, Yan
Mou, Shan
author_sort Wu, Jiajia
collection PubMed
description The contrast-induced acute kidney injury (CI-AKI) has been becoming the third common cause of hospital-acquired acute kidney injury. An ideal animal model is essential for understanding the pathophysiology of CI-AKI. Previous CI-AKI studies were mostly performed on rats with high-osmolar contrast medium (HOCM), which is unsuitable for transgenic researches. This study provides a novel, efficient and reproducible CI-AKI model which was developed in mouse by administrating a low-osmolar contrast medium (LOCM). First of all, we applied the frequently used pretreatments (uninephrectomy and water deprivation), which combined with HOCM on rats could induce CI-AKI, on mice with LOCM. Secondly, we attempted to find a novel pretreatment suitable for mouse and LOCM by combining two classic pretreatments(uninephrectomy, water deprivation and furosemide administration). Finally, we evaluate the kidney damage of the novel model. We found that this mouse model possessed a significant reduction in renal function, severe renal tissue damage, and increased renal tubular cells apoptosis, indicating that LOCM is a feasible inducer for CI-AKI mice model. Taken together, we found that uninephrectomy (UPHT) combined with 24 h water deprivation and furosemide administration 20 min before LOCM (iohexol, 10 ml/kg) application is a feasible pretreatment to establish a novel CI-AKI mouse model.
format Online
Article
Text
id pubmed-9367657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-93676572022-08-12 A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium Wu, Jiajia Shen, Jianxiao Wang, Wanpeng Jiang, Na Jin, Haijiao Che, Xiajing Ni, Zhaohui Fang, Yan Mou, Shan Ren Fail Research Article The contrast-induced acute kidney injury (CI-AKI) has been becoming the third common cause of hospital-acquired acute kidney injury. An ideal animal model is essential for understanding the pathophysiology of CI-AKI. Previous CI-AKI studies were mostly performed on rats with high-osmolar contrast medium (HOCM), which is unsuitable for transgenic researches. This study provides a novel, efficient and reproducible CI-AKI model which was developed in mouse by administrating a low-osmolar contrast medium (LOCM). First of all, we applied the frequently used pretreatments (uninephrectomy and water deprivation), which combined with HOCM on rats could induce CI-AKI, on mice with LOCM. Secondly, we attempted to find a novel pretreatment suitable for mouse and LOCM by combining two classic pretreatments(uninephrectomy, water deprivation and furosemide administration). Finally, we evaluate the kidney damage of the novel model. We found that this mouse model possessed a significant reduction in renal function, severe renal tissue damage, and increased renal tubular cells apoptosis, indicating that LOCM is a feasible inducer for CI-AKI mice model. Taken together, we found that uninephrectomy (UPHT) combined with 24 h water deprivation and furosemide administration 20 min before LOCM (iohexol, 10 ml/kg) application is a feasible pretreatment to establish a novel CI-AKI mouse model. Taylor & Francis 2022-08-08 /pmc/articles/PMC9367657/ /pubmed/35938700 http://dx.doi.org/10.1080/0886022X.2022.2108449 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wu, Jiajia
Shen, Jianxiao
Wang, Wanpeng
Jiang, Na
Jin, Haijiao
Che, Xiajing
Ni, Zhaohui
Fang, Yan
Mou, Shan
A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
title A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
title_full A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
title_fullStr A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
title_full_unstemmed A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
title_short A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
title_sort novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367657/
https://www.ncbi.nlm.nih.gov/pubmed/35938700
http://dx.doi.org/10.1080/0886022X.2022.2108449
work_keys_str_mv AT wujiajia anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT shenjianxiao anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT wangwanpeng anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT jiangna anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT jinhaijiao anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT chexiajing anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT nizhaohui anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT fangyan anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT moushan anovelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT wujiajia novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT shenjianxiao novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT wangwanpeng novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT jiangna novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT jinhaijiao novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT chexiajing novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT nizhaohui novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT fangyan novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium
AT moushan novelcontrastinducedacutekidneyinjurymousemodelbasedonlowosmolarcontrastmedium